These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. [Malignant hyperthermia--still a current and dangerous problem]. Løvstad RZ; Halvorsen P; Steen PA; Lindal S Tidsskr Nor Laegeforen; 1995 May; 115(12):1494-8. PubMed ID: 7770853 [TBL] [Abstract][Full Text] [Related]
47. Anaesthetic management of a parturient patient with a malignant hyperthermia partner. Dolan R; Corcoran F BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35396237 [TBL] [Abstract][Full Text] [Related]
54. Prediction of malignant hyperthermia susceptibility by clinical signs. Larach MG; Rosenberg H; Larach DR; Broennle AM Anesthesiology; 1987 Apr; 66(4):547-50. PubMed ID: 3565822 [No Abstract] [Full Text] [Related]
55. Sufentanil-midazolam anesthesia in malignant hyperthermia. Tuman KJ; Spiess BD; Wong CA; Ivankovich AD Anesth Analg; 1988 Apr; 67(4):405-8. PubMed ID: 2895595 [No Abstract] [Full Text] [Related]
56. Eltanolone (5-beta-pregnanolone) does not trigger, and attenuates halothane triggering of, malignant hyperthermia in malignant hyperthermia susceptible swine. Harrison GG; Dyer RA; Llewellyn RL; James MF Pharmacol Res; 1999 Feb; 39(2):103-6. PubMed ID: 10072700 [TBL] [Abstract][Full Text] [Related]
57. An unusual anesthetic course in a patient susceptible to malignant hyperthermia. Westlund UJ; Fridrich KL; Warner DS; Sokoll MD J Oral Maxillofac Surg; 1989 Aug; 47(8):860-4. PubMed ID: 2664105 [No Abstract] [Full Text] [Related]
58. Manufacturer's response to Bilmen and Gillies' manuscript entitled "clarifying the role of activated charcoal filters in preparing an anaesthetic workstation for malignant hyperthermia-susceptible patients". Orr J; Sakata D Anaesth Intensive Care; 2014 Nov; 42(6):801-2. PubMed ID: 25342416 [No Abstract] [Full Text] [Related]